bng0 bng0 https://www.fiercebiotech.com/r-d/gates-backs-a-120m-breakout-round-for-crispr-cas9-pioneers-at-editas Field: Genetic Engineering Focus: Eyes Type: Private Equity HQ: United States Founded: Investments Name HQ Field Focus Editas Medicine United States Genetic Engineering Eyes